IMUX — Immunic Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Immunic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	127	86.9	116	46.7	35.7
Net Total Receivables	0.295	0.279	0.296	0.703	0.647
Prepaid Expenses
Total Other Current Assets
Total Current Assets	134	105	126	52.5	39.3
Net Property, Plant And Equipment	1.1	1.1	1.85	1.76	1.54
Net Goodwill
Other Long Term Assets
Total Assets	168	139	128	54.3	40.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.4	11.4	13.1	24.7	22.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.08	12	14.1	25.4	22.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	159	127	114	28.9	18.4
Total Liabilities & Shareholders' Equity	168	139	128	54.3	40.9
Total Common Shares Outstanding